ROCK inhibitors in ophthalmology: A critical review of the existing clinical evidence
出版年份 2023 全文链接
标题
ROCK inhibitors in ophthalmology: A critical review of the existing clinical evidence
作者
关键词
-
出版物
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-04-11
DOI
10.1111/ceo.14224
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surgical Management of Fuchs Endothelial Corneal Dystrophy
- (2022) Nizar Din et al. CORNEA
- The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
- (2021) Rei Sakata et al. ADVANCES IN THERAPY
- Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy
- (2021) Marianne O. Price et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty
- (2021) Sabrina L. Chen et al. American Journal of Ophthalmology Case Reports
- Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2
- (2020) Sanjay Asrani et al. ADVANCES IN THERAPY
- Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series
- (2020) C. Ellis Wisely et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
- (2020) Yuko Maruyama et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study
- (2020) Gregory Moloney et al. CORNEA
- Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
- (2020) Hidenobu Tanihara et al. BMC Ophthalmology
- Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
- (2020) Akiko Futakuchi et al. Scientific Reports
- Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients with Open-angle Glaucoma or Ocular Hypertension
- (2020) Inder Paul Singh et al. JOURNAL OF GLAUCOMA
- Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil
- (2020) Stephen A. LoBue et al. CORNEA
- Long Term Side effects Including Blepharitis Leading to Discontinuation of Ripasudil
- (2019) Hitomi Saito et al. JOURNAL OF GLAUCOMA
- Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only
- (2019) Marian S. Macsai et al. CORNEA
- Once-Daily Netarsudil vs Twice-Daily Timolol in Patients with Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study
- (2019) Albert S. Khouri et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Descemetʼs stripping without endothelial keratoplasty
- (2019) Daniel Garcerant et al. CURRENT OPINION IN OPHTHALMOLOGY
- Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial
- (2019) Sanjay Asrani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Descemet Stripping Only for a Chronic Descemet Detachment After Cataract Surgery
- (2019) Kristin E. Hirabayashi et al. CORNEA
- Effects of 0.4% ripasudil hydrochloride hydrate on morphological changes in rabbit eyes
- (2019) Bundit Limratchatamorn International Journal of Ophthalmology
- Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
- (2018) Janet B. Serle et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma
- (2018) Sentaro Kusuhara et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model
- (2018) Yoshifumi Hida et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy
- (2018) Shigeru Kinoshita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
- (2018) Angelo P. Tanna et al. OPHTHALMOLOGY
- Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
- (2018) Hamid Ahmadieh et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Descemetorhexis Without Endothelial Keratoplasty Versus DMEK for Treatment of Fuchs Endothelial Corneal Dystrophy
- (2018) Marshall J. Huang et al. CORNEA
- Reticular Epithelial Edema in Edematous Corneas Treated with Netarsudil
- (2018) Mark M. Fernandez OPHTHALMOLOGY
- One-year efficacy of adjunctive use of Ripasudil, a rho-kinase inhibitor, in patients with glaucoma inadequately controlled with maximum medical therapy
- (2017) Hiroshi Inazaki et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
- (2017) Naoki Okumura et al. Journal of Ophthalmology
- ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy
- (2017) Pierre-Raphaël Rothschild et al. Scientific Reports
- Efficacy of the Additional Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients With Glaucoma Inadequately Controlled Under Maximum Medical Therapy
- (2016) Hiroshi Inazaki et al. JOURNAL OF GLAUCOMA
- Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
- (2016) Naoki Okumura et al. Scientific Reports
- One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension
- (2015) Hidenobu Tanihara et al. ACTA OPHTHALMOLOGICA
- Descemetorhexis for Fuchs’ dystrophy
- (2015) Gregory Moloney et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure
- (2015) Jason Bacharach et al. OPHTHALMOLOGY
- Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost
- (2015) Hidenobu Tanihara et al. JAMA Ophthalmology
- Effects of K-115, a Rho-Kinase Inhibitor, on Aqueous Humor Dynamics in Rabbits
- (2014) Tomoyuki Isobe et al. CURRENT EYE RESEARCH
- Phase 2 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension
- (2013) Hidenobu Tanihara et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema
- (2013) Hamid Ahmadieh et al. JAMA Ophthalmology
- Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115
- (2013) Hidenobu Tanihara JAMA Ophthalmology
- Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease
- (2011) Qian Zhou et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity
- (2010) Mutsuki Amano et al. Cytoskeleton
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now